葛根素
骨质疏松症
核酸
化学
DNA
机制(生物学)
生物物理学
药理学
细胞毒性
临床治疗
作用机理
药品
疾病
螯合作用
纳米技术
四面体
副作用(计算机科学)
治疗效果
组合化学
材料科学
癌症研究
生物信息学
生物活性
作者
Weifei Zhang,Mengqing Li,Fei Yu,Dengbo Yao,Hang Liu,Wenyu Zhou,Hui Zeng,Zhangheng Huang
标识
DOI:10.1002/adhm.202505921
摘要
Osteoporosis is a common disease whose primary treatment currently involves anti-osteoporosis medications. However, these drugs are often inconvenient to administer and are associated with side effects. Therefore, developing new treatments is of significant clinical importance. Puerarin (Pue) is a potential therapeutic agent for osteoporosis, but its poor solubility, low bioavailability, and instability limit its efficacy. In this study, we synthesized a tetrahedral framework nucleic acids(tFNAs)-puerarin complex (TPC) by loading puerarin onto tFNAs. TPC demonstrates enhanced cellular uptake and stability, and shows superior osteogenic activity and anti-osteoporosis effects compared to Pue alone, mediated through the FXR/Runx2 pathway. In summary, we have developed a novel nanocomplex, TPC, with promising therapeutic potential for osteoporosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI